BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 24, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Hospital patient wearing pulse oximeter

Inflarx MAb misses mark in study of severe COVID-19 patients

March 31, 2022
By Michael Fitzhugh
A phase II/III trial testing Inflarx NV's vilobelimab, a monoclonal antibody the company is developing to control inflammatory response, showed a relative reduction in 28-day all-cause mortality of 23.9% vs. placebo (p=0.094) for mechanically ventilated COVID-19 patients, but missed statistical significance on the measure, the study's primary endpoint.
Read More

New shortage threatens Rx supply chain

March 31, 2022
By Mari Serebrov
Throughout the COVID-19 pandemic, biopharma companies across the world have had to deal with shortages resulting from supply chain issues.
Read More

In the clinic for March 31, 2022

March 31, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Smith+Nephew.
Read More

Regulatory actions for March 31, 2022

March 31, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abionyx, Antengene, ASC, Biogen, Guerbet, Hipra, Nurix, Realta, Receptor, Taiho, Viiv.
Read More

In the clinic for March 31, 2022

March 31, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acer, Adagio, Ascletis, Cellphire, Concentric, Genentech, Immutep, Prometheus, Revelation.
Read More

Adagio MAb posts strong data, supporting planned EUA filing

March 30, 2022
By Lee Landenberger
Adagio Therapeutics Inc. plans to file for emergency use authorization in the second quarter of 2022 for its lead candidate, a monoclonal antibody (MAb) for preventing and treating COVID-19. With plenty of competing vaccines around, the company now thinks it has found the right group to receive it: the immunocompromised.
Read More

In the clinic for March 30, 2022

March 30, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo, O'Brien, Synchron, University of Portsmouth.
Read More

Regulatory actions for March 30, 2022

March 30, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antares, Astrazeneca, BMS, Canbridge, CSL, Daewoong, Enanta, Immunogen, Mitsubishi Tanabe, Neurocrine, Novo Nordisk, Noxopharm, Reveragen, Santhera, Takeda, Urogen, Telix.
Read More

Other news to note for March 30, 2022

March 30, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AB, Acelrx, Adocia, Alpha Cognition, Asahi Kasei, Athos, Biosion, Biovaxys, Bone Therapeutics, Brii, Collegium, Cybin, Diurnal, Elicio, Formycon, Graybug, Orchard, Organo, Partner, Polpharma, Pyxis, Qpex, Rainbio, Redx, Scenic, Sinopharm, Sterotherapeutics, Teva, TSB, Vectivbio, Vector, Vyant and Vyne.
Read More

In the clinic for March 30, 2022

March 30, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Aldeyra, Angiocrine, Antios, Aptevo, Bio-Thera, Cullinan, Curevac, Design, Diamond, Galecto, Glaxosmithkline, HDT, Innovent, Krystal, Lannett, Maat, Neuronascent, Neuroplast, Ocuphire, Pfizer, Recce, Recordati, Rejuvenate, Revive, Ribon, Sangamo, Saniona, Scancell, Sumitomo Dainippon, Synthetic, Valbiotis, Vectivbio.
Read More
Previous 1 2 … 119 120 121 122 123 124 125 126 127 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 23, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing